Changes after publication

Changes after publication

October 2013: implementation section updated to clarify that dabigatran etexilate is recommended as an option for preventing stroke and systemic embolism. Additional minor maintenance update also carried out.

June 2012: minor maintenance

  • National Institute for Health and Care Excellence (NICE)